MONOPHARMA

Mono Pharmacare Share Price

 

 

Start SIP in MONOPHARMA

Start SIP

Performance

  • Low
  • ₹15
  • High
  • ₹15
  • 52 Week Low
  • ₹15
  • 52 Week High
  • ₹35
  • Open Price₹15
  • Previous Close₹15
  • Volume2,000

Investment Returns

  • Over 1 Month -34.24%
  • Over 3 Month -34.24%
  • Over 6 Month -43.47%
  • Over 1 Year -58.15%

Smart Investing Starts Here Start SIP with Mono Pharmacare for Steady Growth!

Invest Now

Mono Pharmacare Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 8.2
  • PEG Ratio
  • -
  • Market Cap Cr
  • 26
  • P/B Ratio
  • 0.8
  • Average True Range
  • 0.84
  • EPS
  • 1.75
  • Dividend Yield
  • 0
  • MACD Signal
  • -1.37
  • RSI
  • 28.63
  • MFI
  • 24.85

Mono Pharmacare Financials

Mono Pharmacare Technicals

EMA & SMA

Current Price
₹14.50
-0.7 (-4.61%)
pointer
  • Bearish Moving Average 16
  • Bullish Moving Average 0
  • 20 Day
  • ₹17.24
  • 50 Day
  • ₹19.53
  • 100 Day
  • ₹21.83
  • 200 Day
  • ₹26.00

Resistance and Support

14.5 Pivot Speed
  • R3 14.50
  • R2 14.50
  • R1 14.50
  • S1 14.50
  • S2 14.50
  • S3 14.50

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Mono Pharmacare Ltd has an operating revenue of Rs. 356.98 Cr. on a trailing 12-month basis. An annual revenue growth of 38% is outstanding, Pre-tax margin of 3% needs improvement, ROE of 9% is fair but needs improvement. The company has a debt to equity of 83%, which is bit higher. From an O'Neil Methodology perspective, the stock has an EPS Rank of 41 which is a POOR score indicating inconsistency in earnings, a RS Rating of 5 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at E which indicates heavy supply, Group Rank of 165 indicates it belongs to a poor industry group of Medical-Whlsle Drg/Suppl and a Master Score of E is the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Mono Pharmacare Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-29 Quarterly Results & Others To consider other business matters (Revised)
2025-08-26 Others To consider other business matters
2025-05-30 Audited Results & Others (Revised) To consider other business matters.
2025-04-11 Others To consider other business matters (Revised)
2025-02-10 Others To consider other business matters

Mono Pharmacare F&O

Mono Pharmacare Shareholding Pattern

56.72%
34.47%
8.81%

About Mono Pharmacare

  • NSE Symbol
  • MONOPHARMA
  • BSE Symbol
  • Managing Director
  • Mr. Panilam Lakhatariya
  • ISIN
  • INE0OIP01012

Similar Stocks to Mono Pharmacare

Mono Pharmacare FAQs

Mono Pharmacare share price is ₹14 As on 02 January, 2026 | 03:21

The Market Cap of Mono Pharmacare is ₹25.6 Cr As on 02 January, 2026 | 03:21

The P/E ratio of Mono Pharmacare is 8.2 As on 02 January, 2026 | 03:21

The PB ratio of Mono Pharmacare is 0.8 As on 02 January, 2026 | 03:21

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23